Metastasis Suppressors: Functional Pathways

Overview

Journal Lab Invest

Specialty Pathology

Date 2017 Oct 3

PMID 28967874

Citations 32

Authors

Imran Khan

Patricia S Steeg

Affiliations

Soon will be listed here.

Abstract

Metastasis is a complex process and a major contributor of death in cancer patients. Metastasis suppressor genes are identified by their ability to inhibit metastasis at a secondary site without affecting the growth of primary tumor. In this review, we have conducted a survey of the metastasis suppressor literature to identify common downstream pathways. The metastasis suppressor genes mechanistically target MAPK, G-protein-coupled receptor, cell adhesion, cytoskeletal, transcriptional regulatory, and metastasis susceptibility pathways. The majority of the metastasis suppressor genes are functionally multifactorial, inhibiting metastasis at multiple points in the cascade, and many operate in a context-dependent fashion. A greater understanding of common pathways/molecules targeted by metastasis suppressor could improve metastasis treatment strategies.

Citing Articles

Molecular principles underlying aggressive cancers.

Nussinov R, Yavuz B, Jang H Signal Transduct Target Ther. 2025; 10(1):42.

PMID: 39956859 PMC: 11830828. DOI: 10.1038/s41392-025-02129-7.

Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma.

Sun Z, Hu M, Huang X, Song M, Chen X, Bei J Cancer Cell Int. 2025; 25(1):13.

PMID: 39810206 PMC: 11730157. DOI: 10.1186/s12935-025-03642-z.

A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies.

Li J, Liu W, Mojumdar K, Kim H, Zhou Z, Ju Z Nat Cancer. 2024; 5(10):1579-1595.

PMID: 39227745 DOI: 10.1038/s43018-024-00817-x.

An Overview on the Emerging Role of the Plasma Protease Inhibitor Protein ITIH5 as a Metastasis Suppressor.

Subramaniyam K, Harihar S Cell Biochem Biophys. 2024; 82(2):399-409.

PMID: 38355846 DOI: 10.1007/s12013-024-01227-7.

Metastasis suppressor genes in clinical practice: are they druggable?.

Gelman I Cancer Metastasis Rev. 2023; 42(4):1169-1188.

PMID: 37749308 PMC: 11629483. DOI: 10.1007/s10555-023-10135-w.

References

Geuking P, Narasimamurthy R, Lemaitre B, Basler K, Leulier F . A non-redundant role for Drosophila Mkk4 and hemipterous/Mkk7 in TAK1-mediated activation of JNK. PLoS One. 2009; 4(11):e7709. PMC: 2766050. DOI: 10.1371/journal.pone.0007709. View

Ulitsky I, Bartel D . lincRNAs: genomics, evolution, and mechanisms. Cell. 2013; 154(1):26-46. PMC: 3924787. DOI: 10.1016/j.cell.2013.06.020. View

Stupack D, Teitz T, Potter M, Mikolon D, Houghton P, Kidd V . Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature. 2006; 439(7072):95-9. DOI: 10.1038/nature04323. View

Li Q, Qin Y, Wei P, Lian P, Li Y, Xu Y . Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma. Mol Cancer Res. 2016; 14(9):830-40. DOI: 10.1158/1541-7786.MCR-16-0032. View

Cichon M, Moruzzi M, Shqau T, Miller E, Mehner C, Ethier S . MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer. Cancer Res. 2016; 76(12):3520-30. PMC: 4911305. DOI: 10.1158/0008-5472.CAN-15-3465. View

Su B, Zheng Q, Vaughan M, Bu Y, Gelman I . SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition. Cancer Res. 2006; 66(11):5599-607. DOI: 10.1158/0008-5472.CAN-05-4123. View

Guo L, Gao L, Rothschild J, Su B, Gelman I . Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12. J Biol Chem. 2011; 286(44):38356-38366. PMC: 3207390. DOI: 10.1074/jbc.M111.258830. View

Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, VAN Roy F . Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991; 66(1):107-19. DOI: 10.1016/0092-8674(91)90143-m. View

Kapoor P, Saunders M, Li Z, Zhou Z, Sheaffer N, Kunze E . Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer. 2004; 111(5):693-7. DOI: 10.1002/ijc.20318. View

10.

Theroux S, Pereira M, Casten K, Burwell R, Yeung K, Sedivy J . Raf kinase inhibitory protein knockout mice: expression in the brain and olfaction deficit. Brain Res Bull. 2007; 71(6):559-67. PMC: 1817722. DOI: 10.1016/j.brainresbull.2006.11.010. View

11.

Trakul N, Menard R, Schade G, Qian Z, Rosner M . Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem. 2005; 280(26):24931-40. DOI: 10.1074/jbc.M413929200. View

12.

Deiss K, Kisker C, Lohse M, Lorenz K . Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2. J Biol Chem. 2012; 287(28):23407-17. PMC: 3390617. DOI: 10.1074/jbc.M112.363812. View

13.

Zhang Q, McCorkle J, Novak M, Yang M, Kaetzel D . Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity. Int J Cancer. 2010; 128(1):40-50. PMC: 2946830. DOI: 10.1002/ijc.25307. View

14.

Phadke P, Vaidya K, Nash K, Hurst D, Welch D . BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. Am J Pathol. 2008; 172(3):809-17. PMC: 2258257. DOI: 10.2353/ajpath.2008.070772. View

15.

Miele M, De la Rosa A, Lee J, Hicks D, Dennis J, Steeg P . Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23). Clin Exp Metastasis. 1997; 15(3):259-65. DOI: 10.1023/a:1018473415458. View

16.

ARCH R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P . Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science. 1992; 257(5070):682-5. DOI: 10.1126/science.1496383. View

17.

Crovello C, Furie B, Furie B . Histidine phosphorylation of P-selectin upon stimulation of human platelets: a novel pathway for activation-dependent signal transduction. Cell. 1995; 82(2):279-86. DOI: 10.1016/0092-8674(95)90315-1. View

18.

Vander Griend D, Kocherginsky M, Hickson J, Stadler W, Lin A, Rinker-Schaeffer C . Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res. 2005; 65(23):10984-91. DOI: 10.1158/0008-5472.CAN-05-2382. View

19.

Robinson V, Kauffman E, Sokoloff M, Rinker-Schaeffer C . The basic biology of metastasis. Cancer Treat Res. 2004; 118:1-21. DOI: 10.1007/978-1-4419-9129-4_1. View

20.

Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu N . The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 2005; 65(14):6042-53. PMC: 1360170. DOI: 10.1158/0008-5472.CAN-04-3043. View